AMR
March 30, 2024
First of all, what is your role in the NeoGiANT project? Anitom is leading work package 4, which means that we are responsible for the coordination […]
February 27, 2024
Firstly, what is Bianor’s role in the NeoGiANT project? Bianor Biotech is a technology-based company focused on services and R&D in animal reproduction. Bianor participates in […]
January 29, 2024
Firstly, which is MAGAPOR’s role within the NeoGiANT project? Our role is the development of semen diluents (means of conservation) for the final commercial product, including […]
November 27, 2023
Antimicrobial resistance (AMR) remains a pressing global concern, threatening the effectiveness of antibiotics and posing significant challenges across human health, animal welfare, agriculture, and the environment. […]
May 29, 2023
“The formulations developed at NeoGiANT will provide antimicrobial and antioxidant protection to animals, improving their well-being and acting as preventive therapies. Besides, the project is contributing […]
April 27, 2023
Yesterday, 26th of April, the European Commission made an announcement of a revision of the current pharmaceutical legislation, with several goals and challenges to be addressed, […]
April 27, 2023
Yesterday, 26th of April, the European Commission released a statement to communicate a very important reform to the current pharmaceutical legislation. The main goal is to […]
November 22, 2022
The World Antimicrobial Awareness Week is taking place from 18-24 November 2022 with the slogan “preventing antimicrobial resistance together” During the Sixty-eighth World Health Assembly, held […]
October 24, 2022
The appearance of antimicrobial resistant microorganisms is the cause for infectious diseases, which we used to have under control, to start having a more difficult management. […]
